Andrew Fowell - Concepedia

Author

Andrew Fowell

University of Southampton ORCID

Also Known As

A Fowell, A J Fowell, A. Fowell, A.J. Fowell, Andrew Fowell, Andrew J Fowell, Andrew J. Fowell, Anna Posada, J Crampton

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

University of Southampton Southampton General Hospital National Institute for Health Research Portsmouth Hospitals NHS Trust University College London

About

Andrew Fowell is an author at University of Southampton specializing in medicine, pathology, and palliative care.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	10	2.7K
2	Health Sciences	3	4	1.2K
3	Nursing	3	3	48
4	Public Health	2	2	29
5	Cell Biology	1	1	38

Andrew Fowell

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial Zobair M. Younossi, Vlad Ratziu, Rohit Loomba, The Lancet Interim AnalysisMetabolic Associated SteatohepatitisHepatologyPlacebo-controlled Phase 3Nonalcoholic Fatty Liver Disease	2019	1.2K
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue, Journal of Hepatology FibrosisHepatologyLiver PhysiologyClinical TrialsPathology	2020	438
Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: Results from the WELCOME* study Eleonora Scorletti, Lokpal Bhatia, Keith McCormick, Hepatology PathologyEpa EnrichmentFatty Liver DiseaseObesityMetabolic Syndrome	2014	306
Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Nonalcoholic Fatty Liver Disease Eleonora Scorletti, Paul R. Afolabi, Elizabeth A. Miles, Gastroenterology DysbiosisMicrobiotaGut MicrobiologyLiver FatRandomized Trial	2020	208
Consistent beneficial effects of killer cell immunoglobulin‐like receptor 2DL3 and group 1 human leukocyte antigen‐C following exposure to hepatitis C virus† Susanne Knapp, U. Warshow, Doha Hegazy, Hepatology	2009	156
Primary Rat and Mouse Hepatic Stellate Cells Express the Macrophage Inhibitor Cytokine Interleukin–10 During the Course of Activation In Vitro Kerry C. Thompson, Angus R. Trowern, Andrew Fowell, Hepatology	1998	99
A Polymorphism in IL28B Distinguishes Exposed, Uninfected Individuals From Spontaneous Resolvers of HCV Infection Susanne Knapp, U. Warshow, Kai Man Alexander Ho, Gastroenterology	2011	80
An integrated care pathway for the last two days of life: Wales-wide benchmarking in palliative care Andrew Fowell, Ilora Finlay, Ros Johnstone, International Journal of Palliative Nursing	2002	57
Silencing tissue inhibitors of metalloproteinases (TIMPs) with short interfering RNA reveals a role for TIMP-1 in hepatic stellate cell proliferation Andrew Fowell, Jane Collins, Dale R. Duncombe, Biochemical and Biophysical Research Communications FibrosisLiver PhysiologyMetalloproteinPathologyTissue Inhibitors	2011	38
Tandem mass tag-based quantitative proteomic profiling identifies candidate serum biomarkers of drug-induced liver injury in humans Kodihalli C. Ravindra, Vishal S. Vaidya, Zhenyu Wang, Nature Communications	2023	36

Page 1